4//SEC Filing
Sofia Michael J. 4
Accession 0001140361-18-032008
CIK 0001447028other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 1:11 PM ET
Size
7.7 KB
Accession
0001140361-18-032008
Insider Transaction Report
Form 4
Sofia Michael J.
Chief Scientific Officer
Transactions
- Sale
Common Shares
2018-07-06$8.45/sh−10,000$84,500→ 1,523,403 total - Sale
Common Shares
2018-07-09$8.91/sh−10,000$89,060→ 1,513,403 total
Holdings
- 171,412(indirect: By Trust)
Common Shares
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.50 to $9.35, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the rages set forth in this footnote.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001635324
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 1:11 PM ET
- Size
- 7.7 KB